Skip to content

Author

Alishba Khan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 11617: Cardiovascular Outcomes in Patients with Fatty Change of Liver Treated with Combined GLP-1 RA and SGLT2 Inhibitor Therapy versus GLP-1 RA Alone: A Propensity Score Matched TriNetX Analysis

Background: Fatty change of the liver is strongly associated with cardiovascular risk due to insulin resistance, dyslipidemia, and systemic inflammation. GLP-1 receptor agonists (GLP-1 RAs) and SGLT2 inhibitors (SGLT2is) each provide independent cardiovascular benefits. This study assesses whether combination therap...

M. Azhar, Aneesa Altaf, Ehsanullah Alokozay et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.